Recent Articles

• 
  AI Healthcare

  Vitalyx Taps AI Multi-Agents to Transform Healthcare

  ※ Seoul National University of Science and Technology supports early-stage startups in the deep-tech (AI·Big Data) sector. Based on Seoul National University of Science and Technology’s tailored growth support program, IT Donga examines promising deep-tech startups that are achieving clear results i

  2026.02.23
• 
  Aesthetic

  PharmaResearch Signs License-In Deal for CNT201 with Connext

  Regenerative medicine specialist PharmaResearch announced on the 23rd that it has signed a license-in and supply agreement with clinical-stage biotech venture Connext for the new drug candidate “CNT201.”CNT201 is a biopharmaceutical that is expected to expand into various indications in aesthetic tr

  2026.02.23
• 
  Global Expansion

  CJ CheilJedang, China’s Xinghuipin in Microbe Patent Deal

  On the left is Yan Xiaolin, CEO of Xinghuipin, and on the right is Yoon Seok-hwan, CEO of CJ CheilJedang. (Provided by CJ CheilJedang) CJ CheilJedang announced on the 22nd that it has signed a technology license agreement for lysine, a feed-use amino acid product, with Chinese state-owned enterprise

  2026.02.22
• 
  Biotech

  Engineer Raises KRW 10 Billion for Cell-Based Drug Tests

  On 9 January, Celloid CEO Kim Dong-sung explains well-cultivated mini organs while holding a three-dimensional culture automation system at the company’s research lab in Seocho-gu, Seoul. Mini organs grown in this system show better maturation of vasculature and tissue function compared with convent

  2026.02.21
• 
  AI Biotech

  Alke: AI, Not Intuition, to Optimize Drug Production

  ※ The Entrepreneurship Support Group of Seoul National University of Science and Technology operates a variety of support programs to help startups grow, including the Preliminary and Early Startup Packages and collaboration programs with global companies. IT Donga introduces promising startups that

  2026.02.20
• 
  Clinical Trial

  LG Chem Sets Dose for Phase 3 Head, Neck Cancer Drug

  LG Chem announced on the 20th that it has selected 20mg/kg, the maximum dose, as the final appropriate dosage for its new head and neck cancer drug “ficlatuzumab,” which is currently in Phase 3 clinical trials, and is continuing the study. The clinical trial for ficlatuzumab is being conducted by AV

  2026.02.20
• 
  Biotech

  3Dmem Eyes Nano 3D Printing for Eco-Friendly, High-Performance Membrane Mass Production

  [IT Dong-A x Korea University] Korea University operates the “Crimson Startup Support Group,” a startup incubation and support organization under the direct supervision of the Vice President for Research. In cooperation with the Crimson Startup Support Group, it introduces promising Korea University

  2026.02.20
• 
  Global Business

  KRW 100 Trillion Animal Drug Market Fuels Yuyu Growth

  On the 19th, Yoo Won-sang, CEO of YuYu Pharma, poses for a photo with his companion cat “Rang-i” at the company’s headquarters in Jung-gu, Seoul. YuYu Pharma plans to secure a new growth engine by focusing on the animal pharmaceuticals market, such as cat atopic dermatitis, where drug supply lags be

  2026.02.20
• 
  DTx / Platform

  ‘AI Control Tower’ Enables 70% Stroke Care Within 90 Minutes

  Integrated Response Situation Room at Yongin Severance Hospital, where everything that happens in the hospital can be checked in real time. It also plays a major role in reducing the mortality rate of inpatients. Provided by Yongin Severance Hospital Yongin Severance Hospital, which faced the formid

  2026.02.19
• 
  Startup

  StressSolution Aims to Go Global With Healing Beat

  ※ Kyungpook National University Startup Support Group, together with SKT, operates the “Startup Leap Package (Large Enterprise Collaboration Track)” for startups. It promotes innovative growth by activating startups’ ideas and technological capabilities based on collaboration with large corporations

  2026.02.13